Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature

por Long, Richard, Barrie, James, Peloquin, Charles A.
Publicado 2015

2354. Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for rifampin-resistant or treatment-intolerant TB disease

por Haley, Connie A, Ashkin, David, Peloquin, Charles A
Publicado 2022

1101. Implementing a Beta-Lactam Therapeutic Drug Monitoring Program: Experience from a Large Academic Medical Center

por Veena, Venugopalan, Hamza, Malva, Santevecchi, Barbara A, DeSear, Kathryn, Cherabuddi, Kartikeya, Peloquin, Charles A, Peloquin, Charles A, Al-Shaer, Mohammad H
Publicado 2021

16S rRNA gene sequencing of stool samples collected from patients with latent tuberculosis infection before, during, and two months after treatment with 3HP or 4R

por Séraphin, Marie Nancy, Bellot, Julia, Peloquin, Charles A., Mai, Volker
Publicado 2023

Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach

por Maguigan, Kelly L., Al-Shaer, Mohammad H., Peloquin, Charles A.
Publicado 2021

Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case series

por Alghamdi, Wael A., Al‐Shaer, Mohammad H., Klinker, Kenneth P., Peloquin, Charles A.
Publicado 2020

Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring

por Ashkin, Alex, Alexis, Afe, Ninneman, Megan, Tresgallo, Rene Rico, Ashkin, David, Peloquin, Charles A
Publicado 2023

Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014

por Heysell, Scott K., Moore, Jane L., Peloquin, Charles A., Ashkin, David, Houpt, Eric R.
Publicado 2015

Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion

por Venugopalan, Veena, Manigaba, Kayihura, Borgert, Samuel J, Cope, Jessica, Peloquin, Charles A, Klinker, Kenneth P
Publicado 2018

1411. Noninvasive Assessment of Intralesional Antimicrobial Concentration-Time Profiles in Pulmonary and Central Nervous System Tuberculosis using Dynamic (18)F-Pretomanid Positron...

por Mota, Filipa, Ruiz-Bedoya, Camilo, Tucker, Elizabeth, De Jesus, Patricia, Flavahan, Kelly, Turner, Mitchell, Erice, Clara, Bahr, Melissa, Kim, John, Mahmud, Farina, Peloquin, Charles A, Peloquin, Charles A, Ordonez, Alvaro A, Jain, Sanjay K, Jain, Sanjay K
Publicado 2021

Gut microbiota composition and diversity before, during, and two months after rifamycin-based tuberculosis preventive therapy

por Séraphin, Marie Nancy, Bellot, Julia, Klann, Emily, Ukhanova, Maria, Saulsberry, Florence G., Peloquin, Charles A., Mai, Volker
Publicado 2023

Effect of Rifabutin in Dolutegravir Dosing: A Case Series

por Mendoza, Maria A., Alshaer, Mohammad H., Roldan, Giovanni, Castro, Jose Guillermo, Ashkin, David, Peloquin, Charles A., Boulanger, Catherine V.
Publicado 2022

191. High-Dose Rifampin-containing Regimens for the Treatment of TB Meningitis

por Ruiz-Bedoya, Camilo A, Mota, Filipa, Tucker, Elizabeth, Mahmud, Farina, Erice, Clara, Bahr, Melissa, Flavahan, Kelly, De Jesus, Patricia, Kim, John, Rosa, Marina Da Costa, Yamashita, Alex Shimura, Foss, Catherine A, Peloquin, Charles A, Peloquin, Charles A, Ordonez, Alvaro A, Jain, Sanjay K, Jain, Sanjay K
Publicado 2021

Comparison of the ‘Denver regimen’ against acute tuberculosis in the mouse and guinea pig

por Ahmad, Zahoor, Nuermberger, Eric L., Tasneen, Rokeya, Pinn, Michael L., Williams, Kathy N., Peloquin, Charles A., Grosset, Jacques H., Karakousis, Petros C.
Publicado 2010

Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial

por Browne, Sara H., Umlauf, Anya, Tucker, Amanda J., Low, Julie, Moser, Kathleen, Gonzalez Garcia, Jonathan, Peloquin, Charles A., Blaschke, Terrence, Vaida, Florin, Benson, Constance A.
Publicado 2019

Practices of therapeutic drug monitoring in tuberculosis: an international survey

por Margineanu, Ioana, Akkerman, Onno, Cattaneo, Dario, Goletti, Delia, Marriott, Deborah J.E., Migliori, Giovanni Battista, Mirzayev, Fuad, Peloquin, Charles A., Stienstra, Ymkje, Alffenaar, Jan-Willem
Publicado 2022

Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study

por Zentner, Isaac, Schlecht, Hans P., Khensouvann, Lorna, Tamuhla, Neo, Kutzler, Michele, Ivaturi, Vijay, Pasipanodya, Jotam G., Gumbo, Tawanda, Peloquin, Charles A., Bisson, Gregory P., Vinnard, Christopher
Publicado 2016

1954. Dynamic PET facilitated Modeling and Novel Antibiotic Regimens for Tuberculous Meningitis due to Multidrug-Resistant Strains

por Chen, Xueyi, Nino-Meza, Oscar J, Sarhan, Mona O, Arun, Bhavatharini, Jeon, Byeonghoon, Ordonez, Alvaro A, Carroll, Laurence S, Peloquin, Charles A, Freundlich, Joel, Ivaturi, Vijay, Jain, Sanjay K
Publicado 2023

Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model

por Rosenthal, Ian M, Zhang, Ming, Williams, Kathy N, Peloquin, Charles A, Tyagi, Sandeep, Vernon, Andrew A, Bishai, William R, Chaisson, Richard E, Grosset, Jacques H, Nuermberger, Eric L
Publicado 2007

Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis

por Alffenaar, Jan-Willem C, Gumbo, Tawanda, Dooley, Kelly E, Peloquin, Charles A, Mcilleron, Helen, Zagorski, Andre, Cirillo, Daniela M, Heysell, Scott K, Silva, Denise Rossato, Migliori, Giovanni Battista
Publicado 2020